Differences in the Development of Adverse Infusion Reactions to Rituximab in Patients With Systemic Lupus Erythematosus, Rheumatoid Arthritis and Non-Hodgkin's Lymphoma-Enigma Variations
Open Access
- 16 May 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 9, 882891
Abstract
It has become clear that rituximab treatment is useful for both B-cell malignancies and autoimmune rheumatic diseases. However this treatment is associated with an increased risk of an allergic reaction. We have reviewed the frequency with which these reactions occur in these different conditions. They appear to be less frequent when rituximab is used to treat rheumatoid arthritis and systemic lupus perhaps because concomitant steroids are invariably given to these patients with the rituximab which is not necessarily the case with the treatment of B-cell malignancies.Keywords
This publication has 17 references indexed in Scilit:
- Drug-Specific Th2 Cells and IgE Antibodies in a Patient with Anaphylaxis to RituximabInternational Archives of Allergy and Immunology, 2012
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab studyArthritis & Rheumatism, 2012
- Updated consensus statement on the use of rituximab in patients with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2011
- Anti‐infliximab IgE and non‐IgE antibodies and induction of infusion‐related severe anaphylactic reactionsAllergy, 2010
- Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical TrialsThe Journal of Rheumatology, 2010
- Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatmentJournal of Allergy and Clinical Immunology, 2009
- Monoclonal Antibody First Dose Cytokine Release Syndromes–Mechanisms and PredictionJournal of Immunotoxicology, 2008
- Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2004
- RituximabDrugs, 2003
- An open study of B lymphocyte depletion in systemic lupus erythematosusArthritis & Rheumatism, 2002